Cargando…

Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide

BACKGROUND: Evidence-based guidelines for the management of hypertension are now well established. Studies have shown that more than 60% of patients with hypertension will require two or more drugs to achieve current treatment targets. DISCUSSION: Combination therapy is recommended as first-line tre...

Descripción completa

Detalles Bibliográficos
Autor principal:	Flack, J M
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2007
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228392/ https://www.ncbi.nlm.nih.gov/pubmed/17887997 http://dx.doi.org/10.1111/j.1742-1241.2007.01577.x

Ejemplares similares

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
por: Volpe, Massimo, et al.
Publicado: (2012)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations
por: Kim, Da-Rae, et al.
Publicado: (2013)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Thiazide and thiazide-like diuretics in nephrolithiasis
por: Cunha, Tamara da Silva, et al.
Publicado: (2020)

Response surface analyses of antihypertensive effects of angiotensin receptor blockers and amlodipine or hydrochlorothiazide combination therapy in patients with essential hypertension
por: Cho, Minhee, et al.
Publicado: (2023)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Comparison of thiazide‐like diuretics versus thiazide‐type diuretics: a meta‐analysis
por: Liang, Wenjing, et al.
Publicado: (2017)

Effect of Switching to Azilsartan From Fixed-Dose Combination of an Angiotensin II Receptor Blocker and Calcium Channel Blocker or a Thiazide in Patients With Hypertension
por: Miyoshi, Toru, et al.
Publicado: (2019)

The authors reply to: “Antihypertensives and skin cancer” and “Association between thiazide diuretics and skin cancer: still nebulous”
por: Drucker, Aaron M., et al.
Publicado: (2021)

Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension
por: Shiga, Yuhei, et al.
Publicado: (2017)

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman
por: Al Balushi, K.A., et al.
Publicado: (2013)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Hyperuricemia Associated with Thiazide Diuretics in Hypertensive Adults
por: Raja, Ravi, et al.
Publicado: (2019)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials
por: Magvanjav, Oyunbileg, et al.
Publicado: (2017)

Redefining diuretics use in hypertension: why select a thiazide-like diuretic?
por: Burnier, Michel, et al.
Publicado: (2019)

Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide – which is the better alternative? A meta-analysis
por: Filipova, Elena, et al.
Publicado: (2020)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients
por: Shiga, Yuhei, et al.
Publicado: (2015)

Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers
por: Ekman, Elisabet, et al.
Publicado: (2010)

Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension
por: Huang, Qi-Fang, et al.
Publicado: (2013)

Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized “Z” Studies
por: Omboni, Stefano, et al.
Publicado: (2017)

Zofenopril Plus Hydrochlorothiazide and Irbesartan Plus Hydrochlorothiazide in Previously Treated and Uncontrolled Diabetic and Non-diabetic Essential Hypertensive Patients
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2014)

A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide
por: Khodke, Amol S, et al.
Publicado: (2010)

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study
por: Parhofer, Klaus G, et al.
Publicado: (2007)

Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized “Z” Studies
por: Omboni, Stefano, et al.
Publicado: (2017)

Duloxetine-induced hyponatremia in an elderly patient treated with thiazide diuretics
por: Mori, Miyu, et al.
Publicado: (2014)

Mechanism of Thiazide Diuretic Arterial Pressure Reduction: The Search Continues
por: Rapoport, Robert M., et al.
Publicado: (2019)

Association between thiazide diuretics and skin cancer: still nebulous
por: Parmar, Malvinder S.
Publicado: (2021)

Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats
por: Jin, Kyubok, et al.
Publicado: (2013)

Effectiveness of thiazide and thiazide-like diuretics in advanced chronic kidney disease: a systematic review and meta-analysis
por: Teles, Flávio, et al.
Publicado: (2023)

Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway
por: Hachiya, Kensuke, et al.
Publicado: (2021)

Simultaneous Analysis of Irbesartan and Hydrochlorothiazide: An Improved HPLC Method with the Aid of a Chemometric Protocol
por: Vujić, Zorica, et al.
Publicado: (2012)

Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice
por: Schmieder, Roland E, et al.
Publicado: (2009)

Case report: a thiazide diuretic to treat polyuria induced by tolvaptan
por: Kramers, Bart J., et al.
Publicado: (2018)

Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
por: Mannheimer, Buster, et al.
Publicado: (2021)

Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients
por: Mehanna, Mai, et al.
Publicado: (2021)

Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Bryniarski, Paweł, et al.
Publicado: (2022)

Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials
por: Cuspidi, Cesare, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vn2b5c8h0u1orevkrlnrec83fe